# Progress Note 05 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Rachel Carson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML041-SYN-TD
- Date: 1960-07-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Margaret Vance-Okonkwo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Blocked nose, facial pressure, and cough for five days. **S**

## History of present illness

Ms. Carson is a 53-year-old woman with stage IIB hormone receptor-positive left breast cancer, five weeks into letrozole and on day 8 of her second 28-day cycle of ribociclib. Five days ago she developed a blocked nose, clear then yellow discharge, pressure over both cheeks, a sore throat, and a dry cough. She has had no fever on her home thermometer, checked twice a day as the oncology team taught her, and no chills, breathlessness, or chest pain. The symptoms are no worse than three days ago. She has used saline spray. She called the oncology nurse line, who asked her to be seen today with a blood count. She wanted to know whether this was dangerous on ribociclib and whether she should stop it, and asked for a plain answer. **S**

| Element | Detail |
|---|---|
| Onset | Five days ago |
| Location | Nose, both cheeks, throat |
| Duration | Five days, not worsening |
| Character | Congestion, colored discharge, facial pressure, dry cough |
| Severity | Mild to moderate; writing most mornings |
| Context | Day 8 of ribociclib cycle 2; letrozole daily |
| Modifying factors | Saline spray helps a little |
| Associated signs and symptoms | No fever, breathlessness, chest pain, or ear pain |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; no fever or chills |
| Ears, nose, mouth, and throat | Positive | Blocked nose, colored discharge, cheek pressure, sore throat |
| Respiratory | Positive | Dry cough; no breathlessness or wheeze |
| Cardiovascular | Negative | No palpitations, fainting, or chest pain |
| Gastrointestinal | Negative | No diarrhea, mouth sores, or abdominal pain |
| Integumentary | Negative | No rash; radiation skin healed |

6 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for knee pain, no more than 3000 mg a day **S**
- Letrozole 2.5 mg oral tablet, one tablet by mouth once daily, planned for at least five years **S**
- Ribociclib 200 mg oral tablet, two tablets (400 mg) by mouth once daily on days 1 to 21 of each 28-day cycle, with letrozole, planned for three years **S**
- Zoledronic acid 4 mg in 100 mL intravenous infusion over 15 minutes every six months for three years **S**
- Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/74 mmHg; pulse 82 bpm; respirations 16/min; temperature 37.3 °C; oxygen saturation 98% on room air; weight 59.2 kg; BMI 22.3 kg/m². All vital signs are synthetic.

White cell count: 2.9 10*3/uL (low); Absolute neutrophil count: 1.2 10*3/uL (low); Hemoglobin: 12.2 g/dL; Platelets: 168 10*3/uL. All results are synthetic.

## Change since baseline

- White cell count: 6.4 10*3/uL at baseline, 2.9 10*3/uL (low) at this visit **S**
- Hemoglobin: 12.3 g/dL at baseline, 12.2 g/dL at this visit **S**
- Platelets: 262 10*3/uL at baseline, 168 10*3/uL at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Tired but well-appearing; temperature 37.3 °C |
| Ears, nose, and throat | Swollen nasal lining with mucopurulent discharge; mild tenderness over both maxillary sinuses; throat mildly red without exudate; ear drums normal; no mouth ulcers |
| Neck | Small tender anterior cervical nodes; no supraclavicular nodes |
| Respiratory | Clear on both sides; oxygen saturation 98 percent |
| Cardiovascular | Regular rhythm, 82/min |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Acute viral rhinosinusitis** (J01.90). Five days of symptoms that are not worsening, with no high fever and no worsening after early improvement, fits a viral illness. Colored discharge alone does not mean a bacterial infection, so an antibiotic is not indicated now. **S**
   - Saline irrigation twice a day and acetaminophen as needed, no more than 3000 mg a day; no ibuprofen or naproxen after her ulcer.
   - If symptoms last beyond ten days, worsen after improving, or a fever of 39 °C or more develops, an antibiotic will be needed: amoxicillin-clavulanate, which does not prolong the QT interval.
   - Avoid azithromycin, clarithromycin, levofloxacin, and moxifloxacin, and over-the-counter cough medicines with the same effect, while on ribociclib.
2. **Neutropenia on ribociclib** (C50.412). Absolute neutrophil count 1.2, grade 2, an expected effect of ribociclib, without fever. She was told plainly that this does not make the cold dangerous, and that grade 2 neutropenia does not require stopping or reducing ribociclib. A fever would change that, because infection with a low neutrophil count needs same-day treatment. **S**
   - Continue ribociclib and letrozole without change, after confirming this with the oncology team by telephone.
   - Temperature twice a day; a temperature of 38.0 °C or more, chills, or breathlessness means calling the oncology line the same day, at any hour.
   - Blood count as planned at the start of the next cycle.

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025), National Comprehensive Cancer Network
- KISQALI (ribociclib) tablets: prescribing information (dosage for early breast cancer; QT, hepatotoxicity, and neutropenia monitoring) (2026), U.S. National Library of Medicine, DailyMed
- IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults. Clin Infect Dis 2012;54(8):e72-e112 (2012), Infectious Diseases Society of America

## Follow-up

- Telephone check in three days. Return if symptoms pass ten days or worsen. Oncology blood count at the start of the next cycle. **S**
- Next scheduled visit 1960-09-08: monitoring visit at the start of the fourth ribociclib cycle. **S**
